-
Jul 5, 2010
Circadin® approved in the EU for treatment of Primary Insomnia in patients aged 55 or over for up to 3 months (Read more)
-
Apr 22, 2010
EMEA approves Circadin® use for up to 3 months
-
Jun 11, 2009
Neurim Pharmaceuticals Reports Long Term Efficacy and Safety for Circadin® for Insomnia in Elderly Patients (Read more)
-
Sep 24, 2007
Neurim Pharmaceuticals licenses Circadin®, a drug approved for the treatment of primary insomnia, to Lundbeck
-
Jul 6, 2007
Nycomed to market Circadin® for primary insomnia (Read more)
-
Jun 29, 2007
An Authorisation valid throughout the European Union was issued by the EMEA for Circadin®
-
Apr 27, 2007
Neurim Pharmaceuticals announce that Circadin® for Primary Insomnia is recommended for approval in the EU (Read more)
-
Apr 26, 2007
Summary of positive opinion for Circadin® (EMEA Press Release) (Read more)
